Revised criteria for PCOS in WHO Group II anovulatory infertility - A revival of hypothalamic amenorrhoea?

Clinical Endocrinology

Volumn 82, Issue 4, 2015, Pages 584-591

  Lauritsen, Mette Petri ^a   Pinborg, Anja ^a,b   Loft, Anne ^a   Petersen, Jørgen Holm ^c   Mikkelsen, Anne Lis ^d   Bjerge, Marianne Rich ^d   Nyboe Andersen, Anders ^a  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d HOLBÆK HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; MUELLERIAN INHIBITING FACTOR;

ADULT; ANOVULATION; ARTICLE; COHORT ANALYSIS; ECHOGRAPHY; FEMALE; HIRSUTISM; HUMAN; HYPOTHALAMIC AMENORRHEA; INFERTILITY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MEASUREMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADOLESCENT; AMENORRHEA; BLOOD; BODY MASS; ENDOCRINE SYSTEM; GYNECOLOGY; HYPOTHALAMIC DISEASES; HYPOTHALAMUS; INFERTILITY, FEMALE; METABOLISM; OVARY; OVARY FOLLICLE; PATHOLOGY; PATHOPHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; STANDARDS; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AMENORRHEA; ANOVULATION; ANTI-MULLERIAN HORMONE; BODY MASS INDEX; ENDOCRINE SYSTEM; FEMALE; GYNECOLOGY; HUMANS; HYPOTHALAMIC DISEASES; HYPOTHALAMUS; INFERTILITY, FEMALE; OVARIAN FOLLICLE; OVARY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84924087490     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12621     Document Type: Article

References (34)

1. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41-47.
2. Zawadzki, J.K., &, Dunaif, A., (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In:, A. Dunaif, J.R. Givens, F.P. Haseltine, G.R. Merriam, eds. Polycystic Ovary Syndrome. Blackwell Scientific, Boston, 377-384.
3. Azziz, R., Carmina, E., Dewailly, D., et al,. (2006) Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. Journal of Clinical Endocrinology and Metabolism, 91, 4237-4245.
4. Lujan, M.E., Chizen, D.R., &, Pierson, R.A., (2008) Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. Journal of Obstetrics and Gynaecology Canada, 30, 671-679.
5. WHO Scientific Group. (1973) Agents stimulating gonadal function in the human. World Health Organization Technical Report Series. No. 514.
6. Broekmans, F.J., Knauff, E.A., Valkenburg, O., et al,. (2006) PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG, 113, 1210-1217.
7. Johnstone, E.B., Rosen, M.P., Neril, R.K., et al,. (2010) The polycystic ovary post-Rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. Journal of Clinical Endocrinology and Metabolism, 95, 4965-4972.
8. Lauritsen, M.P., Bentzen, J.G., Pinborg, A., et al,. (2014) The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Human Reproduction, 29, 791-801.
9. Dewailly, D., Gronier, H., Poncelet, E., et al,. (2011) Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Human Reproduction, 26, 3123-3129.
10. de Vet, A., Laven, J.S., de Jong, F.H., et al,. (2002) Anti-Mullerian hormone serum levels: a putative marker for ovarian aging. Fertility and Sterility, 77, 357-362.
11. Lujan, M.E., Jarrett, B.Y., Brooks, E.D., et al,. (2013) Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Human Reproduction, 28, 1361-1368.
12. Dewailly, D., Lujan, M.E., Carmina, E., et al,. (2014) Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Human Reproduction Update, 20, 334-352.
13. Hatch, R., Rosenfield, R.L., Kim, M.H., et al,. (1981) Hirsutism: implications, etiology, and management. American Journal of Obstetrics and Gynecology, 140, 815-830.
14. Adams, J., Franks, S., Polson, D.W., et al,. (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet, 2, 1375-1379.
15. Bartsch, W., (1980) Interrelationships between sex hormone-binding globulin and testosterone, 5 alpha-dihydrotestosterone and oestradiol-17 beta in blood of normal men. Maturitas, 2, 109-118.
16. Fulghesu, A.M., Angioni, S., Belosi, C., et al,. (2006) Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma. Clinical Endocrinology, 65, 396-401.
17. Robin, G., Gallo, C., Catteau-Jonard, S., et al,. (2012) Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea. Journal of Clinical Endocrinology and Metabolism, 97, 4236-4243.
18. Franks, S., (1987) Primary and secondary amenorrhoea. BMJ, 294, 815-819.
19. Pache, T.D., de Jong, F.H., Hop, W.C., et al,. (1993) Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertility and Sterility, 59, 544-549.
20. Balen, A.H., Conway, G.S., Kaltsas, G., et al,. (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduction, 10, 2107-2111.
21. Dewailly, D., Pigny, P., Soudan, B., et al,. (2010) Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Mullerian hormone concentrations aggregate with the markers of hyperandrogenism. Journal of Clinical Endocrinology and Metabolism, 95, 4399-4405.
22. Catteau-Jonard, S., Bancquart, J., Poncelet, E., et al,. (2012) Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome? Ultrasound in Obstetrics & Gynecology, 40, 223-229.
23. Pellatt, L., Hanna, L., Brincat, M., et al,. (2007) Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. Journal of Clinical Endocrinology and Metabolism, 92, 240-245.
24. Gilling-Smith, C., Willis, D.S., Beard, R.V., et al,. (1994) Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. Journal of Clinical Endocrinology and Metabolism, 78, 1158-1165.
25. Iliodromiti, S., Kelsey, T.W., Anderson, R.A., et al,. (2013) Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. Journal of Clinical Endocrinology and Metabolism, 98, 3332-3340.
26. Bentzen, J.G., Forman, J.L., Johannsen, T.H., et al,. (2013) Ovarian antral follicle subclasses and anti-Mullerian hormone during normal reproductive aging. Journal of Clinical Endocrinology and Metabolism, 98, 1602-1611.
27. Schachter, M., Balen, A.H., Patel, A., et al,. (1996) Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone. Gynecological Endocrinology, 10, 327-335.
28. Wang, J.G., &, Lobo, R.A., (2008) The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 93, 1394-1397.
29. Hirvonen, E., (1977) Etiology, clinical features and prognosis in secondary amenorrhea. International Journal of Fertility, 22, 69-76.
30. Hudecova, M., Holte, J., Olovsson, M., et al,. (2009) Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Human Reproduction, 24, 1176-1183.
31. Perkins, R.B., Hall, J.E., &, Martin, K.A., (1999) Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation. Journal of Clinical Endocrinology and Metabolism, 84, 1905-1911.
32. Couzinet, B., Young, J., Brailly, S., et al,. (1999) Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clinical Endocrinology, 50, 229-235.
33. Gordon, C.M., (2010) Functional hypothalamic amenorrhoea. New England Journal of Medicine, 363, 365-371.
34. Jayasena, C.N., Abbara, A., Veldhuis, J.D., et al,. (2014) Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of kisspeptin-54. Journal of Clinical Endocrinology and Metabolism, 99, 953-961.